Variables | Group A (n = 41) | Group B (n = 35) | Group C (n = 29) | p value |
---|---|---|---|---|
Age (± DP) | 60,8 +/- 11 | 59,6 +/- 12 | 54 +/- 12 | 0,038 |
Weight | 69,2 | 71,6 | 74 | 0,4 |
Gender, Male % | 51,2 | 54,2 | 65 | 0,47 |
Test indications: | ||||
CAD investigation or pre-operative % | 46 | 66 | 55 | 0,23 |
Evaluation of known CAD % | 54 | 34 | 45 | 0,23 |
Previous history of MI % | 40 | 26 | 32 | 0,43 |
History of angina % | 58 | 68 | 41 | 0,089 |
History of heart failure % | 39 | 21 | 24 | 0,17 |
Hypertension % | 61 | 62 | 45 | 0,61 |
Diabetes Mellitus % | 20 | 20 | 21 | 0,98 |
High cholesterol % | 46 | 62 | 35 | 0,1 |
Family history for CAD % | 49 | 60 | 46 | 0,49 |
Smoking % | 29 | 31 | 24 | 0,8 |
Obesity % | 36 | 28 | 45 | 0,4 |
Use of Beta blockers % | 49 | 54 | 45 | 0,74 |
Use of calcium channel blockers % | 12 | 20 | 10 | 0,48 |
Use of digitalic % | 0 | 6 | 10 | fp |
Altered baseline ECG % | 38 | 39 | 41 | 0,97 |
Altered baseline ECHO % | 41 | 37 | 42 | 0,87 |
Normal ventricular function % | 66 | 86 | 65 | 0,097 |
Previous CAT % | 46 | 40 | 36 | 0,68 |
Previous PTCA % | 19 | 12 | 10 | 0,6 |
Previous CABG % | 17 | 17 | 10 | 0,69 |